Acceleron Pharma To Host Educational Webcast On Beta-Thalassemia

Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will host and webcast an online educational seminar on beta-thalassemia with Ellis Neufeld, M.D., Ph.D. Acceleron and its collaboration partner, Celgene, are conducting phase 2 clinical trials of sotatercept and luspatercept in patients with beta-thalassemia, MDS, and end-stage renal disease with mineral and bone disorder.

Help employers find you! Check out all the jobs and post your resume.